Product
Concizumab
Aliases
Alhemo
5 clinical trials
7 indications
Indication
Hemophilia A with InhibitorsIndication
Hemophilia B with InhibitorsIndication
Hemophilia AIndication
Hemophilia BIndication
Congenital HemophiliaIndication
Haemophilia BIndication
HaemophiliaClinical trial
Efficacy and Safety of Concizumab Prophylaxis in Patients With Haemophilia A or B With InhibitorsStatus: Active (not recruiting), Estimated PCD: 2021-12-27
Clinical trial
A Multi-centre, Open-label, Single-arm, Non-interventional Post-marketing Study to Investigate Safety and Clinical Parameters of Alhemo® Under Routine Clinical Practice in JapanStatus: , Estimated PCD: 2030-04-30
Clinical trial
Concizumab Compassionate Use Programme for Patients With Congenital HaemophiliaStatus:
Clinical trial
Efficacy and Safety of Concizumab Prophylaxis in Patients With Haemophilia A or B Without InhibitorsStatus: Active (not recruiting), Estimated PCD: 2022-07-12
Clinical trial
Open-label Study Investigating Efficacy, Safety and Pharmacokinetics of Concizumab Prophylaxis in Children Below 12 Years With Haemophilia A or B With or Without InhibitorsStatus: Recruiting, Estimated PCD: 2024-12-01